Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
ORGO
$1.73
-3.63%
ORGO · Organogenesis Holdings Inc.
$1.73
-0.07 (-3.63%)
At close · Aug 17
Market Cap
$230.33M
Shares
128.67M
All earnings calls
Earnings call · FY2026 Q2
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
Forward guidance
2 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$43.76M
-56.7% YoY
Diluted EPS
-$0.77
Net income
-$96.27M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 6, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Total net revenue
Initiated
year ending December 31, 2026
|
$179M – $215M | — | |
|
Second half revenue decline (year over year)
Initiated
second half of 2026
|
64% – 74% | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document